000165511 001__ 165511
000165511 005__ 20231120155326.0
000165511 0247_ $$2pmc$$apmc:PMC9886617
000165511 0247_ $$2doi$$a10.1007/s00415-022-11437-9
000165511 0247_ $$2pmid$$apmid:36308530
000165511 0247_ $$2ISSN$$a0012-1037
000165511 0247_ $$2ISSN$$a0340-5354
000165511 0247_ $$2ISSN$$a0939-1517
000165511 0247_ $$2ISSN$$a1432-1459
000165511 0247_ $$2ISSN$$a1619-800X
000165511 0247_ $$2ISSN$$a0367-004x
000165511 0247_ $$2ISSN$$a0367-004X
000165511 037__ $$aDZNE-2022-01659
000165511 041__ $$aEnglish
000165511 082__ $$a610
000165511 1001_ $$0P:(DE-2719)2812631$$aSchreiber, Stefanie$$b0$$eFirst author$$udzne
000165511 245__ $$aCounteraction of inflammatory activity in CAA-related subarachnoid hemorrhage.
000165511 260__ $$aBerlin$$bSpringer$$c2023
000165511 3367_ $$2DRIVER$$aarticle
000165511 3367_ $$2DataCite$$aOutput Types/Journal article
000165511 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1676382936_8739$$xLetter
000165511 3367_ $$2BibTeX$$aARTICLE
000165511 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000165511 3367_ $$00$$2EndNote$$aJournal Article
000165511 500__ $$aISSN 1432-1459 not unique: **2 hits**.
000165511 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000165511 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x1
000165511 542__ $$2Crossref$$i2022-10-29$$uhttps://creativecommons.org/licenses/by/4.0
000165511 542__ $$2Crossref$$i2022-10-29$$uhttps://creativecommons.org/licenses/by/4.0
000165511 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000165511 650_2 $$2MeSH$$aHumans
000165511 650_2 $$2MeSH$$aSubarachnoid Hemorrhage: complications
000165511 650_2 $$2MeSH$$aSubarachnoid Hemorrhage: diagnostic imaging
000165511 650_2 $$2MeSH$$aCerebral Hemorrhage
000165511 650_2 $$2MeSH$$aBrain
000165511 650_2 $$2MeSH$$aCerebral Amyloid Angiopathy
000165511 650_2 $$2MeSH$$aMagnetic Resonance Imaging
000165511 7001_ $$00000-0001-5627-122X$$aJohn, Anna-Charlotte$$b1
000165511 7001_ $$00000-0002-4624-7995$$aWerner, Cornelius J$$b2
000165511 7001_ $$0P:(DE-2719)2000035$$aVielhaber, Stefan$$b3$$udzne
000165511 7001_ $$0P:(DE-2719)2260426$$aHeinze, Hans-Jochen$$b4$$udzne
000165511 7001_ $$0P:(DE-2719)2810706$$aSpeck, Oliver$$b5$$udzne
000165511 7001_ $$00000-0002-0034-8053$$aWürfel, Jens$$b6
000165511 7001_ $$0P:(DE-HGF)0$$aBehme, Daniel$$b7
000165511 7001_ $$0P:(DE-2719)9002178$$aMattern, Hendrik$$b8$$eLast author$$udzne
000165511 77318 $$2Crossref$$3journal-article$$a10.1007/s00415-022-11437-9$$bSpringer Science and Business Media LLC$$d2022-10-29$$n2$$p1159-1161$$tJournal of Neurology$$v270$$x0340-5354$$y2022
000165511 773__ $$0PERI:(DE-600)1421299-7$$a10.1007/s00415-022-11437-9$$n2$$p1159-1161$$tJournal of neurology$$v270$$x0340-5354$$y2022
000165511 8564_ $$uhttps://pub.dzne.de/record/165511/files/DZNE-2022-01659.pdf$$yOpenAccess
000165511 8564_ $$uhttps://pub.dzne.de/record/165511/files/DZNE-2022-01659.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000165511 909CO $$ooai:pub.dzne.de:165511$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000165511 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812631$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000165511 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2000035$$aExternal Institute$$b3$$kExtern
000165511 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2260426$$aExternal Institute$$b4$$kExtern
000165511 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810706$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000165511 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002178$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b8$$kDZNE
000165511 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000165511 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x1
000165511 9141_ $$y2022
000165511 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000165511 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000165511 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-21$$wger
000165511 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000165511 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000165511 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NEUROL : 2022$$d2023-10-21
000165511 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000165511 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000165511 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000165511 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000165511 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000165511 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000165511 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ NEUROL : 2022$$d2023-10-21
000165511 9201_ $$0I:(DE-2719)1340009$$kAG Speck$$lLinking imaging projects iNET$$x0
000165511 9201_ $$0I:(DE-2719)1310010$$kAG Schreiber$$lMixed cerebral pathologies and cognitive aging$$x1
000165511 9201_ $$0I:(DE-2719)1310005$$kAG Reymann$$lPathophysiology of Dementia$$x2
000165511 980__ $$ajournal
000165511 980__ $$aVDB
000165511 980__ $$aI:(DE-2719)1340009
000165511 980__ $$aI:(DE-2719)1310010
000165511 980__ $$aI:(DE-2719)1310005
000165511 980__ $$aUNRESTRICTED
000165511 9801_ $$aFullTexts
000165511 999C5 $$1N Raposo$$2Crossref$$9-- missing cx lookup --$$a10.1212/WNL.0000000000009036$$pe968 -$$tNeurology$$uRaposo N, Charidimou A, Roongpiboonsopit D, Onyekaba M, Gurol ME, Rosand J et al (2020) Convexity subarachnoid hemorrhage in lobar intracerebral hemorrhage: a prognostic marker. Neurology 94(9):e968–e977. https://doi.org/10.1212/WNL.0000000000009036$$v94$$y2020
000165511 999C5 $$1M Beitzke$$2Crossref$$9-- missing cx lookup --$$a10.1161/STROKEAHA.115.008778$$p1533 -$$tStroke$$uBeitzke M, Enzinger C, Wünsch G, Asslaber M, Gattringer T, Fazekas F (2015) Contribution of convexal subarachnoid hemorrhage to disease progression in cerebral amyloid angiopathy. Stroke 46(6):1533–1540. https://doi.org/10.1161/STROKEAHA.115.008778$$v46$$y2015
000165511 999C5 $$1A Charidimou$$2Crossref$$9-- missing cx lookup --$$a10.1093/brain/awx047$$p1829 -$$tBrain$$uCharidimou A, Boulouis G, Gurol ME, Ayata C, Bacskai BJ, Frosch MP et al (2017) Emerging concepts in sporadic cerebral amyloid angiopathy. Brain 140(7):1829–1850. https://doi.org/10.1093/brain/awx047$$v140$$y2017
000165511 999C5 $$1MG Kozberg$$2Crossref$$9-- missing cx lookup --$$a10.1177/1747493020974464$$p356 -$$tInt J Stroke$$uKozberg MG, Perosa V, Gurol ME, van Veluw SJ (2021) A practical approach to the management of cerebral amyloid angiopathy. Int J Stroke 16(4):356–369. https://doi.org/10.1177/1747493020974464$$v16$$y2021
000165511 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1016/S1474-4422(22)00208-3$$uCharidimou A, Boulouis G, Frosch MP, Baron J-C, Pasi M, Albucher JF et al (2022) The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol 21(8):714–725. https://doi.org/10.1016/S1474-4422(22)00208-3
000165511 999C5 $$1A Corovic$$2Crossref$$9-- missing cx lookup --$$a10.1177/1747493017741569$$p257 -$$tInt J Stroke$$uCorovic A, Kelly S, Markus HS (2018) Cerebral amyloid angiopathy associated with inflammation: a systematic review of clinical and imaging features and outcome. Int J Stroke 13(3):257–267. https://doi.org/10.1177/1747493017741569$$v13$$y2018
000165511 999C5 $$1RW Regenhardt$$2Crossref$$9-- missing cx lookup --$$a10.1001/jamaneurol.2020.1782$$p1261 -$$tJAMA Neurol$$uRegenhardt RW, Thon JM, Das AS, Thon OR, Charidimou A (2020) Association between immunosuppressive treatment and outcomes of cerebral amyloid angiopathy-related inflammation. JAMA Neurol 77(10):1261–1269. https://doi.org/10.1001/jamaneurol.2020.1782$$v77$$y2020